Literature DB >> 24132052

Abnormal brain activity during a reward and loss task in opiate-dependent patients receiving methadone maintenance therapy.

Victoria B Gradin1, Alex Baldacchino2, David Balfour3, Keith Matthews3, J Douglas Steele3.   

Abstract

A core feature of human drug dependency is persistence in seeking and using drugs at the expense of other life goals. It has been hypothesized that addiction is associated with overvaluation of drug-related rewards and undervaluation of natural, nondrug-related rewards. Humans additionally tend to persist in using drugs despite adverse consequences. This suggests that the processing of both rewarding and aversive information may be abnormal in addictions. We used fMRI to examine neural responses to reward and loss events in opiate-dependent patients receiving methadone maintenance treatment (MMT, n=30) and healthy controls (n=23) using nondrug-related stimuli. Half of the patients were scanned after/before daily methadone intake (ADM/BDM patient groups). During reward trials, patients as a whole exhibited decreased neural discrimination between rewarding and nonrewarding outcomes in the dorsal caudate. Patients also showed reduced neural discrimination in the ventral striatum with regard to aversive and nonaversive outcomes and failed to encode successful loss avoidance as a reward signal in the ventral striatum. Patients also showed decreased insula activation during the anticipation/decision phase of loss events. ADM patients exhibited increased loss signals in the midbrain/parahippocampal gyrus, possibly related to a disinhibition of dopamine neurons. This study suggests that patients with opiate dependency on MMT exhibit abnormal brain activations to nondrug-related rewarding and loss events. Our findings add support to proposals that treatments for opiate addiction should aim to increase the reward value of nondrug-related rewarding events and highlight the importance of potential abnormalities in aversive information processing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24132052      PMCID: PMC3924523          DOI: 10.1038/npp.2013.289

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  37 in total

Review 1.  The role of the striatum in aversive learning and aversive prediction errors.

Authors:  Mauricio R Delgado; Jian Li; Daniela Schiller; Elizabeth A Phelps
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-12-12       Impact factor: 6.237

2.  Individual differences in insular sensitivity during loss anticipation predict avoidance learning.

Authors:  Gregory R Samanez-Larkin; Nick G Hollon; Laura L Carstensen; Brian Knutson
Journal:  Psychol Sci       Date:  2008-04

Review 3.  A framework for mesencephalic dopamine systems based on predictive Hebbian learning.

Authors:  P R Montague; P Dayan; T J Sejnowski
Journal:  J Neurosci       Date:  1996-03-01       Impact factor: 6.167

4.  Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal.

Authors:  G J Wang; N D Volkow; J S Fowler; J Logan; N N Abumrad; R J Hitzemann; N S Pappas; K Pascani
Journal:  Neuropsychopharmacology       Date:  1997-02       Impact factor: 7.853

Review 5.  Functional neuroimaging of reward processing and decision-making: a review of aberrant motivational and affective processing in addiction and mood disorders.

Authors:  Esther Kristina Diekhof; Peter Falkai; Oliver Gruber
Journal:  Brain Res Rev       Date:  2008-07-21

Review 6.  Neurocircuitry of addiction.

Authors:  George F Koob; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 7.  Imaging dopamine's role in drug abuse and addiction.

Authors:  N D Volkow; J S Fowler; G J Wang; R Baler; F Telang
Journal:  Neuropharmacology       Date:  2008-06-03       Impact factor: 5.250

8.  Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse.

Authors:  Christoph Fehr; Igor Yakushev; Nina Hohmann; Hans-Georg Buchholz; Christian Landvogt; Hanna Deckers; Alexandra Eberhardt; Marie Kläger; Michael N Smolka; Armin Scheurich; Thomas Dielentheis; Lutz G Schmidt; Frank Rösch; Peter Bartenstein; Gerhard Gründer; Mathias Schreckenberger
Journal:  Am J Psychiatry       Date:  2008-03-03       Impact factor: 18.112

9.  Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder.

Authors:  Diego A Pizzagalli; Avram J Holmes; Daniel G Dillon; Elena L Goetz; Jeffrey L Birk; Ryan Bogdan; Darin D Dougherty; Dan V Iosifescu; Scott L Rauch; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2009-05-01       Impact factor: 18.112

Review 10.  Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction.

Authors:  Barry J Everitt; David Belin; Daina Economidou; Yann Pelloux; Jeffrey W Dalley; Trevor W Robbins
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

View more
  23 in total

1.  Anticipatory reward processing among cocaine-dependent individuals with and without concurrent methadone-maintenance treatment: Relationship to treatment response.

Authors:  Sarah W Yip; Elise E DeVito; Hedy Kober; Patrick D Worhunsky; Kathleen M Carroll; Marc N Potenza
Journal:  Drug Alcohol Depend       Date:  2016-07-16       Impact factor: 4.492

Review 2.  Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.

Authors:  Sarah C Akerman; Mary F Brunette; Alan I Green; Daisy J Goodman; Heather B Blunt; Sarah H Heil
Journal:  J Subst Abuse Treat       Date:  2014-12-22

3.  Impaired neural response to negative prediction errors in cocaine addiction.

Authors:  Muhammad A Parvaz; Anna B Konova; Greg H Proudfit; Jonathan P Dunning; Pias Malaker; Scott J Moeller; Tom Maloney; Nelly Alia-Klein; Rita Z Goldstein
Journal:  J Neurosci       Date:  2015-02-04       Impact factor: 6.167

4.  Intact responses to non-drug rewards in long-term opioid maintenance treatment.

Authors:  Marie Eikemo; Philipp P Lobmaier; Mads L Pedersen; Nikolaj Kunøe; Anna Maria Matziorinis; Siri Leknes; Monica Sarfi
Journal:  Neuropsychopharmacology       Date:  2019-03-31       Impact factor: 7.853

5.  Neuroimaging Impaired Response Inhibition and Salience Attribution in Human Drug Addiction: A Systematic Review.

Authors:  Anna Zilverstand; Anna S Huang; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Neuron       Date:  2018-06-06       Impact factor: 17.173

Review 6.  The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex.

Authors:  Ahmet O Ceceli; Charles W Bradberry; Rita Z Goldstein
Journal:  Neuropsychopharmacology       Date:  2021-08-18       Impact factor: 7.853

7.  Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder.

Authors:  Brian D Kiluk; Sarah W Yip; Elise E DeVito; Kathleen M Carroll; Mehmet Sofuoglu
Journal:  Clin Psychol Sci       Date:  2019-09-23

8.  Exaggerated acquisition and resistance to extinction of avoidance behavior in treated heroin-dependent men.

Authors:  Jony Sheynin; Ahmed A Moustafa; Kevin D Beck; Richard J Servatius; Peter A Casbolt; Paul Haber; Mahmoud Elsayed; Lee Hogarth; Catherine E Myers
Journal:  J Clin Psychiatry       Date:  2016-03       Impact factor: 4.384

9.  Increased neural activity in the right dorsolateral prefrontal cortex during a risky decision-making task is associated with cocaine use in methadone-maintained patients.

Authors:  Andrew S Huhn; Robert K Brooner; Mary M Sweeney; Sarah W Yip; Hasan Ayaz; Kelly E Dunn
Journal:  Drug Alcohol Depend       Date:  2019-10-20       Impact factor: 4.492

10.  Can neuroimaging help combat the opioid epidemic? A systematic review of clinical and pharmacological challenge fMRI studies with recommendations for future research.

Authors:  Hestia Moningka; Sarah Lichenstein; Patrick D Worhunsky; Elise E DeVito; Dustin Scheinost; Sarah W Yip
Journal:  Neuropsychopharmacology       Date:  2018-10-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.